Drugs - Special Access to Drugs and Health Products

The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2020-05-05

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data